Inovio: Successful Phase 2 Trial in Cervical Dysplasia Provides Proof of Concept for the Technology Base (INO, $12.98, Neutral, Subscribers Only)Friday, July 25, 2014 · 9:18 am |
|
This Could Be the Coming Out Year for Inovio (INO, $0.72)Monday, January 21, 2013 · 10:45 am |
|
There are 2 reports on file. |